BOSTON, Aug. 1, 2016 /PRNewswire/ -- BTL Aesthetics today announced that it has received a new designation from the Food & Drug Administration (FDA) for its award-winning, non-invasive fat reduction treatment, BTL Vanquish ME. The physician-favored treatment is now FDA-cleared for the circumferential reduction of the abdomen and thighs. The clearance was secured following several rounds of clinical testing to provide ample evidence of its efficacy and safety—which has also been previously documented thanks to two studies published in peer-reviewed journals.
"We're excited to receive our latest FDA clearance, as it further demonstrates the versatility of the BTL Vanquish ME system and its efficacy," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "This clearance, which was secured in part thanks to extensive clinical research, is truly a further testament to BTL Vanquish ME's superior and consistent results."
Harnessing the power of high-frequency, Selective RF energy, BTL Vanquish ME induces death of fat cells through apoptosis, and the body flushes fat cells out of the body naturally to help slim the abs, belly, love handles, and now thighs. Boasting the largest spot size in the industry, the unique contactless panel allows patients to treat a broad area at once, resulting in more even results with no lines of demarcation. Similarly to treatment of the abdomen, which covers the core from flank-to-flank, the Flex Applicator—specially designed to treat and adjust to the thighs—simultaneously slims both the inner/outer thighs and saddle bags. This allows for enhanced patient outcomes, shorter treatment times and elimination of additional consumable costs for the physician—a sharp contrast to similar systems which focus solely on smaller areas or specific fat deposits, making BTL Vanquish ME a more affordable treatment option.
"The upper legs continue to be a common area of complaint for my patient base, with many inquiring about procedures to help slim, shape, and tone thighs," says Dr. Annie Chiu, Board Certified Dermatologist and founder of The Derm Institute in Redondo Beach, CA. "With the BTL Vanquish ME Flex Applicator at my practice, we have been able to treat both the inner and outer thigh in each session at the same time, giving patients a circumferential reduction in their thighs and a slimmer leg appearance," added Chiu.
This newest distinction further supports previous studies published in peer-reviewed journals including Dermatologic Therapy and the Journal of Drugs and Dermatology both of which highlight the effectiveness of BTL Aesthetics' patented radio frequency technology to reduce the circumference of thighs. In clinical studies, over 80% of subjects experienced a statistically high and significant circumferential reduction with four, 30-minute treatment sessions per leg, delivered once a week over a four week period.
BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit btlaesthetics.com to find a physician for treatment.
About BTL Industries
Founded in 1993, BTL Industries is a privately owned developer and manufacturer of medical and aesthetic equipment. BTL currently has over 1,050 employees and direct offices in more than 53 countries.
BTL Aesthetics, a division of BTL, has revolutionized the way to non-invasively remove adipose tissue; it currently ranks 2nd among the non-invasive body shaping and tightening manufacturers globally. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis Ultra, and BTL Cellutone.
Additional information can be found at http://www.btlaesthetics.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/getting-a-leg-up-on-body-shaping-btl-aesthetics-announces-fda-clearance-for-thighs-300306789.html
SOURCE BTL Aesthetics